
Zalunfiban Shows Promise at AHA Scientific Sessions
Key highlights
- Zalunfiban shows efficacy in STEMI treatment
- Phase 3 trial conducted on 2,467 patients
- Quick antiplatelet effects aid emergency response
- Developed with support from Harrington Discovery Institute
- A promising advancement in cardiovascular medicine
Source: PR Newswire
Notable Quotes



